SMTL ID : 5trf.7 (7 other biounits)

MDM2 in complex with SAR405838

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.10 Å

Oligo State

homo-dimer

Ligands

2 x 7HC: (2'S,3R,4'S,5'R)-6-chloro-4'-(3-chloro-2-fluorophenyl)-2'-(2,2-dimethylpropyl)-N-(trans-4-hydroxycyclohexyl)-2-oxo-1,2-dihydrospiro[indole-3,3'-pyrrolidine]-5'-carboxamide(Non-covalent)

7HC.1: 19 residues within 4Å: Chain A: V.5, T.7, L.45, L.48, G.49, I.52, M.53, Y.58, H.64, F.77, F.82, V.84, H.87, I.90, Y.91 Chain B: T.1, Q.50, M.53 Ligands: GOL.3 15 PLIP interactions: 13 interactions with chain A, 2 interactions with chain B Hydrophobic interactions: A:V.5, A:V.5, A:T.7, A:L.45, A:L.45, A:L.48, A:Y.58, A:F.82, A:V.84, A:V.84, B:Q.50 Hydrogen bonds: A:L.45 pi-Stacking: A:H.87 Halogen bonds: A:H.87 Water bridges: B:T.54 7HC.4: 16 residues within 4Å: Chain A: Q.50 Chain B: V.5, T.7, L.45, L.48, G.49, I.52, M.53, Y.58, F.77, F.82, V.84, H.87, I.90, Y.91 Ligands: GOL.3 14 PLIP interactions: 14 interactions with chain B Hydrophobic interactions: B:V.5, B:T.7, B:L.45, B:L.45, B:L.48, B:I.52, B:Y.58, B:F.82, B:V.84, B:V.84, B:I.90 Hydrogen bonds: B:L.45 pi-Stacking: B:H.87 Halogen bonds: B:H.87

2 x GOL: GLYCEROL(Non-functional Binders)

GOL.2: 8 residues within 4Å: Chain A: A.4, V.5, T.6, K.42 Chain B: A.4, V.5, T.6, K.42 6 PLIP interactions: 4 interactions with chain B, 2 interactions with chain A Hydrogen bonds: B:A.4, B:T.6, B:T.6, B:T.6, A:T.6 Water bridges: A:T.6 GOL.3: 6 residues within 4Å: Chain A: F.46, G.49, Q.50 Chain B: V.5 Ligands: 7HC.1, 7HC.4 No protein-ligand interaction detected (PLIP)

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Wang, S. et al., SAR405838: an optimized inhibitor of MDM2-p53 interaction that induces complete and durable tumor regression. Cancer Res. (2014)

Release Date

2016-11-09

Peptides

E3 ubiquitin-protein ligase Mdm2: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

B
D

E3 ubiquitin-protein ligase Mdm2

Related Entries With Identical Sequence